Loss-of-function variants in TREM2 increase AD risk (Benitez et al., 2013; Jin et al., 2014; Jin et al., 2015; Jonsson et al., 2013; Guerreiro et al., 2013). This evidence concerns the gene TREM2 and Alzheimer disease.